AtaiBeckley ATAI
NASDAQ ATAI
$7.39 +0.05 (+0.68%)
As of: Sep 4, 2026 · 3:59 PM EDT

AtaiBeckley (ATAI) Change in Acquisitions & Divestments (2022 - 2025)

AtaiBeckley (ATAI) posted Change in Acquisitions & Divestments of -$11.1 million for Q3 2025, down 200.0% sequentially from $11.1 million in Q2 2025, and up 85.12% YoY from -$6.0 million in Q3 2024.

Analysis

AtaiBeckley (ATAI) Change in Acquisitions & Divestments (2022 - 2025) Analysis & Trends

AtaiBeckley has reported Change in Acquisitions & Divestments for 4 years, with the latest figure at -$11.1 million in Q3 2025.

  • Quarterly Change in Acquisitions & Divestments rose 85.12% year-over-year to -$11.1 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $11.3 million (down 94.14% YoY) and the FY2024 annual result came in at $65.6 million, down 52.83% from the prior year.
  • Change in Acquisitions & Divestments retreated to -$11.1 million in Q3 2025 per ATAI's latest filing, from $11.1 million in the prior quarter.
  • Over five years, Change in Acquisitions & Divestments peaked at $226.8 million in Q4 2022 and troughed at -$74.3 million in Q3 2024.
  • A 4-year average of $39.2 million and a median of $17.7 million in 2023 frame the typical range for Change in Acquisitions & Divestments.
  • The widest YoY moves for Change in Acquisitions & Divestments: up 377.87% in 2024, down 102.49% in 2024.
  • Over 4 years, Change in Acquisitions & Divestments stood at $226.8 million in 2022, then sank by 38.94% to $138.5 million in 2023, then sank by 91.85% to $11.3 million in 2024, then tumbled by 197.95% to -$11.1 million in 2025.
  • According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered -$11.1 million, $11.1 million, and $11.3 million for Q3 2025, Q2 2025, and Q4 2024 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 AtaiBeckley 1.61 Bn 1.61 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 -11.06 Mn
Jun 30, 2025 11.06 Mn
Dec 31, 2024 11.29 Mn
Sep 30, 2024 -74.35 Mn
Jun 30, 2024 84.78 Mn
Mar 31, 2024 43.84 Mn
Dec 31, 2023 8.62 Mn
Sep 30, 2023 93.16 Mn
Jun 30, 2023 17.74 Mn
Mar 31, 2023 19.46 Mn
Dec 31, 2022 226.83 Mn